Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled date : 2021 - 08 - 03 save search
Amgen Reports Second Quarter 2021 Financial Results
Published: 2021-08-03 (Crawled : 23:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.05%
H: 1.86%
C: 1.67%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.21%
H: 4.53%
C: 4.06%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.4%
H: 1.51%
C: 1.38%
financial results results report
Eli Lilly in the News: COVID-19, Q2 and Ad Drama
Published: 2021-08-03 (Crawled : 15:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
covid covid-19
Iterative Scopes Raises $30 Million Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.27%
H: 1.02%
C: 0.96%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
Gennao Bio Appoints Dale L. Ludwig, Ph.D., as Chief Scientific Officer
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -1.6%
H: 1.86%
C: 1.68%
covid enroll
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K
|
|
| O: 1.14%
H: 0.0%
C: -1.56%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: 0.5%
H: 0.5%
C: -6.44%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -1.21%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 0.9%
H: 1.45%
C: 0.67%
financial results results liver
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Published: 2021-08-03 (Crawled : 10:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
covid baricitinib covid-19
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
Published: 2021-08-03 (Crawled : 09:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.